250 related articles for article (PubMed ID: 1320354)
21. Cytostatic effect of homo-aza-steroidal esters in vivo and in vitro. Structure-activity relationships.
Catsoulacos P; Camoutsis C; Papageorgiou A; Adamiak-Margariti E
Anticancer Res; 1992; 12(5):1617-20. PubMed ID: 1444229
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
[TBL] [Abstract][Full Text] [Related]
23. Anti-tumor effect of dithiole compounds.
Yoshida E; Fukami T; Takamiya K; Okura A
Anticancer Drug Des; 1988 Aug; 3(2):129-32. PubMed ID: 3408549
[TBL] [Abstract][Full Text] [Related]
24. Alkylphosphonium salts as a new class of antitumor agents.
Sanyal U; Chatterjee RS; Das SK; Chakraborti SK
Neoplasma; 1984; 31(2):149-55. PubMed ID: 6717684
[TBL] [Abstract][Full Text] [Related]
25. The antitumour activity of a series of benzothiophenes.
Hellmann K; Marshall PG; Stayt S
Biochem Pharmacol; 1967 Apr; 16(4):681-7. PubMed ID: 6033788
[No Abstract] [Full Text] [Related]
26. [Problem of screening of antineoplastic drugs in tissue and cell cultures].
Dobrynin IaV
Eksp Onkol; 1985; 7(2):9-15. PubMed ID: 4006851
[TBL] [Abstract][Full Text] [Related]
27. Antineoplastic activity of new linear hydrazine derivatives.
Fiszer-Maliszewska L; Peczyńska-Czoch W; Wieczorek J; Mordarski M; Balicki R; Nantka-Namirski P
Arch Immunol Ther Exp (Warsz); 1987; 35(2):225-35. PubMed ID: 3447537
[TBL] [Abstract][Full Text] [Related]
28. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
[TBL] [Abstract][Full Text] [Related]
29. Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors.
Akaike Y; Arai Y; Taguchi H; Satoh H
Gan; 1982 Jun; 73(3):480-7. PubMed ID: 7129012
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and evaluation of novel 6-chloro-/fluorochromone derivatives as potential topoisomerase inhibitor anticancer agents.
Ishar MP; Singh G; Singh S; Sreenivasan KK; Singh G
Bioorg Med Chem Lett; 2006 Mar; 16(5):1366-70. PubMed ID: 16332438
[TBL] [Abstract][Full Text] [Related]
32. [Acceleration of growth of transplantable tumors and change in the sensitivity to chemotherapy on administration of creatinine].
Pukhal'skaia ECh; Platonova GN
Biull Eksp Biol Med; 1971 Oct; 72(10):82-5. PubMed ID: 5126158
[No Abstract] [Full Text] [Related]
33. Anticancer activity of the structurally novel antibiotic Cl-920 and its analogues.
Leopold WR; Shillis JL; Mertus AE; Nelson JM; Roberts BJ; Jackson RC
Cancer Res; 1984 May; 44(5):1928-32. PubMed ID: 6546897
[TBL] [Abstract][Full Text] [Related]
34. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.
Watanabe M; Komeshima N; Nakajima S; Tsuruo T
Cancer Res; 1988 Dec; 48(23):6653-7. PubMed ID: 3180075
[TBL] [Abstract][Full Text] [Related]
35. N-bromoacetyl-beta-D-glucosamine tetra-O-acetate and N-bromoacetyl-beta-D-galactosamine tetra-O-acetate as chemotherapeutic agents with immunopotentiating effects in Ehrlich ascites tumor-bearing mice.
Simon P; Burlingham WJ; Conklin R; Fondy TP
Cancer Res; 1979 Oct; 39(10):3897-902. PubMed ID: 476625
[No Abstract] [Full Text] [Related]
36. Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.
Shimomura K; Manda T; Mukumoto S; Masuda K; Nakamura T; Mizota T; Matsumoto S; Nishigaki F; Oku T; Mori J
Cancer Res; 1988 Mar; 48(5):1166-72. PubMed ID: 3342397
[TBL] [Abstract][Full Text] [Related]
37. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors.
Leopold WR; Nelson JM; Plowman J; Jackson RC
Cancer Res; 1985 Nov; 45(11 Pt 1):5532-9. PubMed ID: 4053027
[TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of cyclocytidine in a variety of tumors.
Hoshi A; Kanzawa F; Kuretani K
Gan; 1972 Jun; 63(3):353-60. PubMed ID: 5072834
[No Abstract] [Full Text] [Related]
39. Effect of proteinase inhibitor in experimental tumors.
Lage A; Díaz JW; González I
Neoplasma; 1978; 25(2):257-9. PubMed ID: 205810
[TBL] [Abstract][Full Text] [Related]
40. [The effect of cycloferon administration on the growth of transplantable tumors in rats and mice].
Zabezhinskiĭ MA; Popovich IG; Shtylik AV; Kovalenko AL; Anisimov VN
Vopr Onkol; 1998; 44(4):427-31. PubMed ID: 9807206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
